United Therapeutics Corporation (UTHR)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 2,877,400 | 2,327,500 | 1,936,300 | 1,685,500 | 1,483,300 |
| Property, plant and equipment | US$ in thousands | — | — | 861,500 | 780,900 | 731,600 |
| Fixed asset turnover | — | — | 2.25 | 2.16 | 2.03 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $2,877,400K ÷ $—K
= —
United Therapeutics Corporation's fixed asset turnover has shown a positive trend over the past few years, increasing from 2.03 in December 2020 to 2.16 in December 2021 and further to 2.25 in December 2022. This indicates that the company is generating more revenue per dollar of fixed assets invested, which is a positive sign of operational efficiency.
However, the data also shows that fixed asset turnover figures are not available for December 2023 and December 2024. This may indicate a lack of data availability or fluctuations in the company's fixed asset utilization during those periods, which should be considered when evaluating the company's overall performance.
Overall, the improving trend in fixed asset turnover up to December 2022 suggests that United Therapeutics Corporation has been utilizing its fixed assets effectively to generate revenue. Further analysis and monitoring would be needed to understand the reasons behind the missing data points and to assess the company's ongoing operational efficiency.
Peer comparison
Dec 31, 2024